Jim Datin

The North Carolina Courage are multi-year champions of the National Women’s Soccer League (NWSL), the highest division of women’s professional soccer in the United States. Formerly the Western New York Flash, Steve Malik relocated the team to North Carolina in 2017 and named the team the North Carolina Courage, giving a nod to the Carolina Courage of the WPS, the first professional women’s soccer team in the state. The team defeated the Portland Thorns 3-0 to become the 2018 NWSL Champions. The team then beat the Chicago Red Stars 4-0 to win back-to-back titles. The team has won three-consecutive NWSL Shields and also won the 2018 Women’s International Champions Cup. On January 22, 2021, tennis superstar Naomi Osaka was named an owner of the team.

BioAgilytix is a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development. With laboratory locations in North Carolina’s Research Triangle Park; Cambridge, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of therapeutics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, GLP, and GCP, as well as GMP quality control testing (i.e., product release testing, stability testing, etc.) BioAgilytix also offers diagnostic testing services at its CLIA-certified, CAP-accredited Boston laboratory. BioAgilytix’s team of highly experienced scientific and QA professionals ensures high-quality science, data integrity and regulatory compliance through all phases of clinical development. BioAgilytix is a trusted partner to many top global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.

Sotera is a Digital Health company developing a new generation of vital signs monitoring technology. Our vision is to revolutionize patient safety by enabling the early detection of deterioration in patients who are mobile and free to move about in the hospital or the home. With adequate warning of adverse events, clinicians can intervene more quickly and confidently and patient outcomes can be improved. Sotera's ViSi Mobile System is a platform for comprehensive vital signs monitoring; designed to keep clinicians connected to their patients, whether in or out of bed, or while in transport . Featuring comfortable body-worn sensors that allow for freedom of movement, the system enables highly accurate, continuous monitoring of all vital signs. The ViSi Mobile System is able to continuously measure and display all vital signs (ECG, Heart/Pulse Rate, SpO2, Blood Pressure [cuff-based and now also cuffless on a beat-to-beat basis], Respiration Rate, Skin Temperature] with monitoring accuracy and resolution typically found in the ICU. ViSi Mobile is a comprehensive system, designed to enhance patient safety by allowing early detection of patient deterioration and connecting clinicians with their patients anywhere, any time.

Putney is a pharmaceutical company specializing in the development of high quality drugs for pets. We focus on developing generics for frequently used drugs where cost is a barrier to prescribing, compliance or use. Our mission: Partner with veterinary practices to provide high quality medicines that meet pet medical needs and offer cost-effective medicines for pet owners Help vets grow their practices and improve margins by offering the quality, security, speed and cost savings of world class pharmaceutical development and sourcing to the veterinary channel Support veterinary drug choice by providing education to help vets evaluate the best treatment options for their pet patients Our first priority is to our customers—veterinarians in the U.S. who care for companion animals (dogs and cats). Putney is built on trust and respect, high ethical standards, high quality products, and on confidential relationships in the industry we serve and our manufacturing partners, suppliers and vendors who help us serve the industry well.

NovaSom is a privately held diagnostic-service provider for home testing and evaluation of obstructive sleep apnea (OSA). As an innovator and pioneer in our field, we developed the first FDA-cleared device designed for unattended, unassisted patient use for the diagnosis of sleep apnea, with clinically proven equivalence * to conventional polysomnography (PSG). NovaSom works with physicians, private insurers, government and public health organizations to address concerns about the large numbers of individuals with undiagnosed sleep apnea. It is our shared concern that millions of Americans are utilizing more health care resources and incurring greater health care costs because their OSA has not been properly diagnosed or treated. It is also our belief that early diagnosis and treatment of OSA can improve lives and help hold down health care costs. Our mission is to improve the health care and quality of life of those impacted by sleep disorders through innovative diagnostic services and by promoting adherence to prescribed therapies.

For over 20 years, Esprida has been helping customers collect, manage and visualize their data to gain insights, identify anomalies, improve efficiency and control their processes. We are trusted experts for bringing our customer’s IoT visions to market for the manufacturing, retail, financial services, government, and agriculture sectors. We also build custom solutions to help customers bridge the gap between their separate software applications, so all critical data is available for visualizing their operations and processes. Based on our Lean IoT™ methodology, Esprida makes each deployment rapid and issue-free. Our process is about creating a minimum viable product (MVP) that addresses the highest priority risk (business or technology) items early. Using an agile development framework allows our customers to participate in the entire implementation process and affords the whole team the ability to evaluate progress, adjust the solution design, and re-prioritize solution components easily throughout the implementation process. As a Microsoft Partner, we leverage the vast array of Microsoft Azure services and infrastructure to rapidly develop, deploy and evaluate proof-of-concept solutions, build out these solutions seamlessly, and quickly scale the solution environment to meet the demands. The Azure platform’s unprecedented level of security provides our customer confidence that their data is secure and protected. There’s a good chance you’ve already benefited from one of Esprida’s retail, digital signage or manufacturing IoT solutions.

Signifi Solutions is at the forefront of the automated retail industry providing innovative solutions to create exceptional customer experiences, expand brand presence, and increase revenues. With an intuitive touchscreen interface and state of the art robotics, Signifi's kiosks dispense premium electronics and luxury goods, pharmaceutical products and specialty packaged foods. By managing design, manufacturing and post installation services, Signifi is able to reduce complexity and costs for its North American and international clients. Signifi works collaboratively with its clients providing brand building asset management services and technology solutions.

Global Healthcare Opportunities, or GHO Capital, was founded in 2014 as a specialist healthcare investment adviser based in London. The firm was built from a shared experience and long-standing history of creating and backing businesses, accelerating growth, delivering value and championing success in the sector through prior roles with healthcare industry leader Quintiles, 3i Group, J.P. Morgan and TPG. We actively evaluate companies with a European presence and global potential within the four healthcare sub-sectors of Outsourced services, PharmaBio, MedTech and Patient services. Our sourcing strategy is based upon a combination of expert healthcare sub-sector knowledge and a global network of industry relationships. Our experienced leadership team brings a unique fusion of private equity, investment banking and industry competencies. The team is designed to provide insight and expertise in supporting company growth and maximising potential. We work alongside management teams who benefit from our proprietary insight and unfettered access to our unique global platform of experience, resource and expert networks. For more information please visit www.ghocapital.com.

The North Carolina Courage are multi-year champions of the National Women’s Soccer League (NWSL), the highest division of women’s professional soccer in the United States. Formerly the Western New York Flash, Steve Malik relocated the team to North Carolina in 2017 and named the team the North Carolina Courage, giving a nod to the Carolina Courage of the WPS, the first professional women’s soccer team in the state. The team defeated the Portland Thorns 3-0 to become the 2018 NWSL Champions. The team then beat the Chicago Red Stars 4-0 to win back-to-back titles. The team has won three-consecutive NWSL Shields and also won the 2018 Women’s International Champions Cup. On January 22, 2021, tennis superstar Naomi Osaka was named an owner of the team.

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers.

BioAgilytix is a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development. With laboratory locations in North Carolina’s Research Triangle Park; Cambridge, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of therapeutics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, GLP, and GCP, as well as GMP quality control testing (i.e., product release testing, stability testing, etc.) BioAgilytix also offers diagnostic testing services at its CLIA-certified, CAP-accredited Boston laboratory. BioAgilytix’s team of highly experienced scientific and QA professionals ensures high-quality science, data integrity and regulatory compliance through all phases of clinical development. BioAgilytix is a trusted partner to many top global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.